Joseph H. Holthoff profile photo

Joseph H. Holthoff

Assistant Professor

Last publication 2025 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

7 h-index 37 pubs 782 cited

Biography and Research Information

OverviewAI-generated summary

Joseph H. Holthoff's research focuses on understanding and identifying biomarkers for acute kidney injury (AKI), particularly in the context of cardiothoracic surgery. His work investigates specific molecules, such as SOD1, urinary complement C3, and vitamin D-binding protein, as potential indicators of adverse outcomes in patients with AKI. Dr. Holthoff also explores the role of proteins like Esm-1 in diabetic kidney disease and IGFBP-1 in the clinical prognosis and pathophysiology of AKI. His investigations extend to other kidney-related conditions, including polycystic kidney disease and membranous nephropathy, and he has examined the efficacy of different treatments for hypermagnesemia. Dr. Holthoff collaborates with researchers at the University of Arkansas for Medical Sciences, including Nithin Karakala, Luis A. Juncos, Manisha Singh, and Fatima Ayub. He has authored 37 publications, with an h-index of 7 and over 775 citations.

Metrics

  • h-index: 7
  • Publications: 37
  • Citations: 782

Selected Publications

  • Perfusion Under Pressure: Reversing Anuric AKI with Targeted Intra-Abdominal Pressure (IAP) Reduction (2025)
  • The Second Slice Tells the Story: Evolving Cryoglobulinemia in Mesangial Glomerulonephritis (2025)
  • Dialysate Sodium (2025)
  • SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series (2025)
  • Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy (2025)
    2 citations DOI OpenAlex
  • The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025)
    1 citation DOI OpenAlex
  • Breaking Barriers: Unconventional Therapy Treats a Challenging Case of Primary Membranous Nephropathy (2024)
    1 citation DOI OpenAlex
  • New Mutation Associated with Polycystic Kidney Disease Type I: A Case Report (2024)
  • Urine Chemistry: A Valuable Link Binding Kidney Physiology to Patient Care (2024)
  • New Mutation Associated with Polycystic Kidney Disease Type I: A Case Report (2024)
    3 citations DOI OpenAlex
  • I Am the Lucky Third: Spontaneous Resolution of High-Risk Membranous Nephropathy (2023)
    1 citation DOI OpenAlex
  • The Drug that Keeps Giving: Hypomagnesemia Fixed by SGLT2 Inhibitor (2023)
    1 citation DOI OpenAlex
  • SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023)
    4 citations DOI OpenAlex
  • SAT145 Familial Renal Glycosuria - A Differential Diagnosis For Hypoglycemia (2023)
  • Hemodialysis Is More Effective Than Continuous Venovenous Hemodialysis for Treatment of Hypermagnesemia due to Epsom Salt Ingestion (2022)
    1 citation DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

  • Investigating the mechanism of protection of IGFBP-1 in a murine model of acute kidney injury Dialysis Clinic, Inc. Principal Investigator
  • Preclinical evaluation of resveratrol in sepsis-induced renal injury NIH Principal Investigator
  • Investigating the mechanism of protection of IGFBP-1 in a murine model of acute kidney injury Dialysis Clinic, Inc. Principal Investigator

Collaboration Network

52 Collaborators 6 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics